JEFFERSON LAB SEARCH

(Show results from this date)
(Show results to this date)
*Use spaces between key words, no punctuation needed *Sign In for authenticated content

  • Welcome to the Jefferson Lab Colloquium page. Find information on the newest upcoming colloquia that will be hosted here at Jefferson Lab. Our next Colloquium is listed below, please see the archive for upcoming colloquium.

    Keep an eye out for this and more events in the JLab Weekly.


    Our Next Speaker:

  • News:

     Preparations for a call for proposals for the 2024 funding cycle are underway.

     

    Our mission:

  • The Electron-Ion Collider (EIC) is a particle accelerator facility planned for construction at Brookhaven National Laboratory (BNL) in partnership with the Jefferson Lab (JLab) to address the following key science questions:

  • If your activity group wishes to be supported by the JAG Committee, just click on a particular form above and fill out the form electronically. Contact Mary Jo Bailey x7183 for more information.

    [ Definitions & Rules ] [ Equipment Request ] [ Funding Request ]

  • Sensitive pre-clinical biomedical imaging is critical for conducting animal studies in search of cures for diseases in people and animals. Jefferson Lab has already drawn on its expertise in detector technology to design and build several small-animal imagers for biomedical research. These tools are already being used for basic research into diseases such as Alzheimer’s, Parkinson’s and cystic fibrosis.

  • After years of design, construction and testing, Jefferson Lab is installing a state-of-the-art Gas Electron Multiplier (GEM) tracking detector in one of its experimental areas. The detector tracks charged particles, such as those emitted by cancer cells tagged with a radiopharmaceutical or radiation beams used to target cancers. The extreme precision and fast readout technologies developed for the GEM detectors are now being applied to new state-of-the-art systems for nuclear medicine. 

  • A medical isotope made from radioactive copper, called Cu-67, is an important therapeutic analog for image-guided radiopharmaceutical therapy for cancer and inflammatory diseases. Jefferson Lab is studying the viability of using its Low Energy Recirculator Facility to produce Cu-67 in a novel way, which may result in another avenue to secure this rare and valuable radioisotope for use in the patients who need it most.